Ola Brazil: Latin America’s BIGGEST Market Accelerates
Brazil is familiar territory to the pharmaceutical industry, which has been operating in the country for decades. Today, with its stronger economic outlook, political stability, and a public healthcare system that gives all residents access to basic treatment, Brazil offers great expansion opportunities to companies.
According to a report from Cutting Edge Information, Emerging Markets Clinical Development Series, Brazil is on the verge of emerging into a world power, perhpas even surpassing the other BRIC countries (Russia, India, and China). It is already the largest market in Latin America, representing 38% of the market compared with 21% for Mexico, 16% for Venezuela, and 9% for Argentina.
Brazil’s healthcare spending represents almost 8% of GDP, and of its population of nearly 200 million people, 20% have private insurance and make us both private and public-health services.
- Kim Ribbink
PharmaVoice Magazine, PharmaVoice
To read the full article, please click here:
http://www.pharmavoice.com/pdfs/2011/pv-0111/PV0111_OlaBrazil.pdf
About PharmaVoice
PharmaVOICE magazine, reaching more than 25,000 BPA-qualified life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally, PharmaVOICEMarketplace.com provides a comprehensive directory of products, services, and solutions for the life-sciences industry.
To Raise Your VOICE, contact feedback@pharmavoice.com.
